Induced pluripotent stem (iPS) cells and their future in psychiatry

Neuropsychopharmacology

Volumn 35, Issue 1, 2010, Pages 346-348

  Kim, Kwang Soo ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DIFFERENTIATION; DNA TRANSFECTION; DNA VECTOR; EMBRYONIC STEM CELL; HUMAN; MENTAL DISEASE; NEUROBIOLOGY; NEUROPSYCHIATRY; NONHUMAN; PATHOGENESIS; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PSYCHIATRY; SHORT SURVEY; VIRAL GENE DELIVERY SYSTEM;

CELL CULTURE TECHNIQUES; GENETIC TECHNIQUES; HUMANS; MENTAL DISORDERS; PLURIPOTENT STEM CELLS; TISSUE THERAPY;

EID: 72049114493     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2009.108     Document Type: Short Survey

References (7)

1. Hyman SE (2008). A glimmer of light for neuropsy-chiatric disorders. Nature 455: 890-893.
2. Kim D, Kim CH, Moon JI, Chung YG, Chang MY, Han BS et al (2009). Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4: 472-476.
3. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA et al (2008). Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451: 141-146.
4. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K et al (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
5. Takahashi K, Yamanaka S (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
6. Yamanaka S (2009). A fresh look at iPS cells. Cell 137: 13-17.
7. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S et al (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.